a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with KALV. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then KALV could also see price increases.
Ticker / NAME | Correlation To ATXS | 1D Price Change % | ||
---|---|---|---|---|
ATXS | 100% | -6.30% | ||
KALV - ATXS | 41% Loosely correlated | -7.62% | ||
ADCT - ATXS | 38% Loosely correlated | -5.86% | ||
FULC - ATXS | 37% Loosely correlated | -5.26% | ||
SNDX - ATXS | 37% Loosely correlated | -0.05% | ||
INZY - ATXS | 36% Loosely correlated | -5.60% | ||
More |
Ticker / NAME | Correlation To ATXS | 1D Price Change % |
---|---|---|
ATXS | 100% | -6.30% |
biotechnology theme (248 stocks) | 43% Loosely correlated | +5.56% |
drugs theme (265 stocks) | 42% Loosely correlated | +5.37% |
treatment theme (61 stocks) | 42% Loosely correlated | +0.91% |
metabolic theme (5 stocks) | 36% Loosely correlated | +0.71% |
cardiovascular theme (12 stocks) | 36% Loosely correlated | +0.92% |
More |